{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:04:55Z","timestamp":1790823895734,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jiac.2021.10.027","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:29:22Z","timestamp":1636504162000},"page":"242-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1943-4648","authenticated-orcid":false,"given":"Yoshikazu","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sadamasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Sugishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.10.027_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s101560100016","article-title":"A study of quality assessment in clinical microbiology performance of independent laboratories in Tokyo: 18-year participation in the Tokyo Metropolitan Government External Quality Assessment Program","volume":"7","author":"Kumasaka","year":"2001","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.10.027_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2021.10.027_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2021.10.027_bib4","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1515\/cclm-2020-1183","article-title":"Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing","volume":"58","author":"Haselmann","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jiac.2021.10.027_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114202","article-title":"Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account","volume":"295","author":"Malecki","year":"2021","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jiac.2021.10.027_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104537","article-title":"First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences","volume":"129","author":"G\u00f6rzer","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jiac.2021.10.027_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1515\/cclm-2020-1602","article-title":"Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR","volume":"59","author":"Buchta","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jiac.2021.10.027_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jmoldx.2020.10.008","article-title":"External quality assessment for molecular detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in clinical laboratories","volume":"23","author":"Wang","year":"2021","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jiac.2021.10.027_bib9","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3201\/eid2610.202551","article-title":"Nationwide external quality assessment of SARS-CoV-2 molecular testing, South Korea","volume":"26","author":"NSung","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.10.027_bib10","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.27.2001223","article-title":"RECOVER project and collaborating networks. International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April\/May 2020","volume":"25","author":"Matheeussen","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2021.10.027_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02676-20","article-title":"Variable sensitivity of SARS-CoV-2 molecular detection in European expert laboratories: external quality assessment, June and July 2020","volume":"59","author":"Fischer","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.10.027_bib12","article-title":"The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications","author":"Bank","year":"2020","journal-title":"Clin Chem Lab Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:31Z","timestamp":1761159811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1341321X21003007"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.10.027","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}